HPPH

N/A

Report date: 2022/11/09 13:45:49
NME

Base Information

Drug NameHPPH
Drug Alias NameHPPH
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhotosensitizers
TargetsNot applicable
Therapy Area/IndicationsGranuloma, Lethal MidlineBarrett EsophagusPrecancerous Conditions +[34] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesZhejiang Hisun Pharmaceutical Co LtdBeijing Collab Pharm Co LtdRoswell Park Cancer Institute
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesZhejiang Hisun Pharmaceutical Co Ltd
Inactive CompaniesRoswell Park Cancer Institute
Active IndicationsBarrett EsophagusSkin NeoplasmsEsophageal Neoplasms
Inactive IndicationsGranuloma, Lethal MidlinePrecancerous ConditionsCarcinoma, Non-Small-Cell Lung +[31] 

Other Information

ATC CodeN/A
Related LinksWikipedia